NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH
loading...

The Landscape of US Generic Prescription Drug Markets, 2004-2016

Ernst R. Berndt, Rena M. Conti, Stephen J. Murphy

NBER Working Paper No. 23640
Issued in July 2017

---- Acknowledgments ----

Mr. Berndt and Mr. Murphy acknowledge research support from the National Institutes of Health, National Institute on Aging, Grant R01AG043560, to the National Bureau of Economic Research. Ms. Conti acknowledges research support from The Commonwealth Fund and the American Cancer Society. The University of Chicago’s Institutional Review Board deemed this study exempt. Data support from Michael Kleinrock at QuintilesIMS is gratefully acknowledged, as are helpful discussions on FDA regulatory matters with Kurt Karst of Hyman, Phelps and McNamara PC. Any opinions and findings expressed here are those of the authors, are not necessarily those of the institutions with whom they are affiliated, the research sponsors or the individuals providing information. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page

 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us